FR2551750B1 - 3-acylamino-2-oxo-1-azetidinyl-b-oxypropionates a action therapeutique - Google Patents

3-acylamino-2-oxo-1-azetidinyl-b-oxypropionates a action therapeutique

Info

Publication number
FR2551750B1
FR2551750B1 FR8414074A FR8414074A FR2551750B1 FR 2551750 B1 FR2551750 B1 FR 2551750B1 FR 8414074 A FR8414074 A FR 8414074A FR 8414074 A FR8414074 A FR 8414074A FR 2551750 B1 FR2551750 B1 FR 2551750B1
Authority
FR
France
Prior art keywords
oxypropionates
azetidinyl
acylamino
oxo
therapeutic action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8414074A
Other languages
English (en)
Other versions
FR2551750A1 (fr
Inventor
Henner Straub
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2551750A1 publication Critical patent/FR2551750A1/fr
Application granted granted Critical
Publication of FR2551750B1 publication Critical patent/FR2551750B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR8414074A 1983-09-14 1984-09-13 3-acylamino-2-oxo-1-azetidinyl-b-oxypropionates a action therapeutique Expired FR2551750B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53198783A 1983-09-14 1983-09-14

Publications (2)

Publication Number Publication Date
FR2551750A1 FR2551750A1 (fr) 1985-03-15
FR2551750B1 true FR2551750B1 (fr) 1986-08-01

Family

ID=24119929

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8414074A Expired FR2551750B1 (fr) 1983-09-14 1984-09-13 3-acylamino-2-oxo-1-azetidinyl-b-oxypropionates a action therapeutique

Country Status (6)

Country Link
JP (1) JPS6084263A (fr)
CA (1) CA1243679A (fr)
DE (1) DE3433676A1 (fr)
FR (1) FR2551750B1 (fr)
GB (1) GB2147292A (fr)
IT (1) IT1175725B (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939253A (en) * 1982-08-04 1990-07-03 E. R. Squibb & Sons, Inc. 2-oxoazetidin-1-yloxy acetic acids and analogs

Also Published As

Publication number Publication date
CA1243679A (fr) 1988-10-25
IT8422652A0 (it) 1984-09-13
IT1175725B (it) 1987-07-15
GB2147292A (en) 1985-05-09
GB8422991D0 (en) 1984-10-17
DE3433676A1 (de) 1985-03-28
JPS6084263A (ja) 1985-05-13
FR2551750A1 (fr) 1985-03-15

Similar Documents

Publication Publication Date Title
DK162816C (da) Medicinsk elektrodeaggregat
ATA903584A (de) Schneeraeumgeraet
DK62984D0 (da) Doseringsapparat
IT1180022B (it) Manipolo dentistico
IT1180021B (it) Manipolo dentistico
ES281919Y (es) Un electrodo biomedico
FR2572725B1 (fr) Ethers bicycloheptane-substitues a action therapeutique
ATA277484A (de) Traufausbildung
FR2564845B1 (fr) Mercaptocycloalkylcarbonyl et mercaptoarylcarbonyl dipeptides a action therapeutique
FI843266A0 (fi) Terapeutiska aemnen.
IT1176037B (it) Ciclino piezoelettrico
FR2516924B1 (fr) Acides phosphinylalcanoyl- amines a action therapeutique
FR2533566B1 (fr) Imino- et amino-acides acyloxycetone-substitues a action therapeutique
FR2544098B1 (fr) Programmateur
FR2551750B1 (fr) 3-acylamino-2-oxo-1-azetidinyl-b-oxypropionates a action therapeutique
RO86393A2 (fr) Medicament a action vasculaire-trombocitaire
RO86649A2 (fr) Medicament a action antiterramateuse
KR850001234U (ko) 자침용 침관
IT8340410A0 (it) Ionerba terapia
SE8304893D0 (sv) Injektionsspruta
KR840006347U (ko) 귀영식 적산계
KR840007030U (ko) 모형
BR6802792U (pt) Boneco articulado
IT1172488B (it) Macchina terapeutica
PT7516U (pt) Capsula inviolavel

Legal Events

Date Code Title Description
ST Notification of lapse